SEC Form 4 · accession 0001104659-16-135074
AGILE THERAPEUTICS INC · AGRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Seth H. Z. Fischer
Director
Period of report
Jul 28, 2016
Accepted (ET)
Jul 28, 2016 · 6:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001261249
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $6.78 | Jul 28, 2016 | A | 21,000 | A | — | Jul 27, 2026 | Common Stock | 21,000 | 21,000 | D |
Explanation of responses
- F1The option vests in three equal annual installments beginning on July 28, 2017, subject to the Reporting Person's continued service on the Issuer's board of directors through each vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during each respective year of board service.